- Supported exchanges /
- KQ /
- 235980.KQ
MedPacto Inc (235980 KQ) stock market data APIs
₩4980
-370(-6.9%)
as of November 25, 2024
Price chart is built with Anychart
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors. MedPacto, Inc. is based in Seoul, South Korea.
MedPacto Inc Financial Data Overview
5350 | |
4980 | |
- | |
6020 | |
4845 | |
4420-17240 | |
159 173 M | |
33 581 K | |
0 | |
-52.2233 | |
0.7835 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'235980',
Type:
'Common Stock',
Name:
'MedPacto Inc',
Exchange:
'KQ',
CurrencyCode:
'KRW',
CurrencyName:
'Korean Won',
CurrencySymbol:
'₩',
CountryName:
'Korea',
CountryISO:
'KR',
OpenFigi:
'BBG00QT4TP96',
ISIN:
NULL,
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
MedPacto Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -29 874 405 376
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get MedPacto Inc Earnings via APIs
- Latest Release 2024-11-04
- EPS/Forecast NaN
Get MedPacto Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: